We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$3.67B
AUM Growth
+$466M
Cap. Flow
+$376M
Cap. Flow %
10.25%
Top 10 Hldgs %
20.64%
Holding
541
New
33
Increased
186
Reduced
105
Closed
34

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$33.6M
2
ANDV
Andeavor
ANDV
+$24.3M
3
DD icon
DuPont de Nemours
DD
+$21.7M
4
AAPL icon
Apple
AAPL
+$21.4M
5
BALL icon
Ball Corp
BALL
+$18.6M

Sector Composition

Rank Sector Weight
1 Industrials 17.89%
2 Consumer Discretionary 13.49%
3 Financials 11.92%
4 Technology 9.21%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEP icon
51
American Electric Power
AEP
$67.1B
$22M 0.6%
362,380
+81,121
+29% +$4.64M
PFE icon
52
Pfizer
PFE
$161B
$21.9M 0.6%
740,021
+5,507
+0.7% +$158K
TRN icon
53
Trinity Industries
TRN
$2.35B
$21.8M 0.59%
1,079,213
+184,703
+21% +$4.45M
TIP icon
54
iShares TIPS Bond ETF
TIP
$15.1B
0
R icon
55
Ryder
R
$9.57B
$21.1M 0.57%
226,853
+88,333
+64% +$7.88M
GS icon
56
Goldman Sachs
GS
$303B
$21M 0.57%
108,296
+50,660
+88% +$9.52M
POR icon
57
Portland General Electric
POR
$5.9B
$20.9M 0.57%
551,316
+45,215
+9% +$1.64M
INTC icon
58
Intel
INTC
$467B
$20.7M 0.56%
570,075
+148,141
+35% +$5.15M
FITB
59
Fifth Third Bancorp
FITB
$50B
$20.3M 0.55%
996,165
-101,670
-9% -$2.02M
OCR
60
DELISTED
OMNICARE INC
OCR
$20.1M 0.55%
275,382
-1,310
-0.5% -$88.9K
LQD icon
61
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
0
PNC icon
62
PNC Financial Services
PNC
$97.6B
$19.7M 0.54%
215,771
+31,668
+17% +$2.74M
CVSA
63
Covista Inc
CVSA
$4.69B
$19.5M 0.53%
409,956
+97,163
+31% +$4.57M
NNI icon
64
Nelnet
NNI
$4.57B
$19.4M 0.53%
418,565
+25
+0% +$1.14K
ARW icon
65
Arrow Electronics
ARW
$10.6B
$19.1M 0.52%
330,690
-194,692
-37% -$10.8M
CF icon
66
CF Industries
CF
$19B
$18.6M 0.51%
341,115
-153,735
-31% -$8.11M
AET
67
DELISTED
Aetna Inc
AET
$18.4M 0.5%
206,869
+205,779
+18,879% +$17.3M
HUN icon
68
Huntsman Corp
HUN
$1.69B
$18.2M 0.5%
800,988
+11,487
+1% +$279K
COF icon
69
Capital One
COF
$133B
$18.1M 0.49%
219,521
+201,846
+1,142% +$16.4M
LDL
70
DELISTED
Lydall, Inc.
LDL
$18.1M 0.49%
550,843
+365,533
+197% +$10.6M
CE icon
71
Celanese
CE
$4.91B
$17.9M 0.49%
298,708
+105,068
+54% +$6.14M
FLOT icon
72
iShares Floating Rate Bond ETF
FLOT
$10.6B
0
SKX
73
DELISTED
Skechers
SKX
$17.4M 0.47%
945,561
+497,340
+111% +$9.29M
IM
74
DELISTED
Ingram Micro
IM
$17.4M 0.47%
629,260
-271,538
-30% -$7.15M
IEF icon
75
iShares 7-10 Year Treasury Bond ETF
IEF
$43.1B
0

Similar funds

James Investment Research's Q4 2014 Portfolio in Review

As of Q4 2014, James Investment Research held 541 positions worth $3.67B, up 15% from $3.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

James Investment Research deployed $376M of net new capital in Q4 2014, opening 33 new positions and adding to 186 existing holdings. Its largest new stake was FedEx: 82,911 shares worth $14.4M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was CIMAREX ENERGY CO, an estimated $33.7M trimmed.

  • James Investment Research's largest Q4 2014 buy was FedEx: 82,911 shares worth $14.4M.
  • James Investment Research added most to Keurig Dr Pepper in Q4 2014, an estimated $33.6M increase.
  • James Investment Research's biggest Q4 2014 reduction was CIMAREX ENERGY CO, cutting an estimated $33.7M.
  • James Investment Research fully exited AK Steel Holding Corp in Q4 2014, selling an estimated $5.5M.
  • James Investment Research's ten largest holdings make up 21% of its $3.67B portfolio in Q4 2014.
  • James Investment Research opened 33 new positions and closed 34 in Q4 2014.
  • James Investment Research's portfolio value rose 15% quarter-over-quarter to $3.67B.

Based on James Investment Research's 13F filing for Q4 2014, filed 9 Jan 2015.